Mark Wijnen

Mark Wijnen is a Researcher at Erasmus MC's Department of Internal Medicine, specializing in endocrinology, metabolic disorders, and bone health. His work focuses on craniopharyngioma patients, investigating outcomes of bariatric surgery, bone mineral density changes, and metabolic complications. He contributed to a 16-year longitudinal study on fractures and growth in craniopharyngioma patients and explored romosozumab treatment effects on spinal fractures. He held an external position from 2019–2020 but details are unspecified.

Key research themes include hypothalamic obesity management, antidiabetic drug-cardiovascular interactions, and longitudinal analysis of bone health in rare endocrine conditions. His recent studies highlight clinical applications of bariatric surgery in specialized patient cohorts and pharmacological interventions in osteoporosis.